Striking similarity

Vivus Inc. (NASDAQ:VVUS) has steadfastly opposed the director slate put forward by First Manhattan, but some of the biotech's recent board additions bear a striking similarity with those on the activist shareholder's wish list. The company's investor base will have the final say at the July 15 annual general meeting.